Characterization of a CNS penetrant, selective M 1 muscarinic receptor agonist, 77‐LH‐28‐1
Langmead, C J, Austin, N E, Branch, C L, Brown, J T, Buchanan, K A, Davies, C H, Forbes, I T, Fry, V A H, Hagan, J J, Herdon, H J, Jones, G A, Jeggo, R, Kew, J N C, Mazzali, A, Melarange, R, Patel, N, Pardoe, J, Randall, A D, Roberts, C, Roopun, A, Starr, K R, Teriakidis, A, Wood, M D, Whittington, M, Wu, Z, Watson, J
Published in British journal of pharmacology (01.07.2008)
Published in British journal of pharmacology (01.07.2008)
Get full text
Journal Article
Nitric Oxide Function in an Echinoderm
Elphick, Maurice R., Melarange, Richard
Published in The Biological bulletin (Lancaster) (01.06.1998)
Published in The Biological bulletin (Lancaster) (01.06.1998)
Get full text
Journal Article
The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism
Melarange, R., Spangler, R., Hoult, J.R.S.
Published in Prostaglandins, leukotrienes and essential fatty acids (01.09.1996)
Published in Prostaglandins, leukotrienes and essential fatty acids (01.09.1996)
Get full text
Journal Article
Comparison of the anti-inflammatory activity and gastrointestinal irritancy of nabumetone, ibuprofen, and diclofenac in rats following chronic administration
Melarange, R, Blower, P, Spangler, R
Published in European journal of rheumatology and inflammation (1994)
Get more information
Published in European journal of rheumatology and inflammation (1994)
Journal Article
Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia
Robbins, Melanie J, Starr, Kathryn R, Honey, Andy, Soffin, Ellen M, Rourke, Claire, Jones, Gareth A, Kelly, Fiona M, Strum, Jay, Melarange, Rosemary A, Harris, Andy J, Rocheville, Magalie, Rupniak, Tom, Murdock, Paul R, Jones, Declan N.C, Kew, James N.C, Maycox, Peter R
Published in Brain research (04.06.2007)
Published in Brain research (04.06.2007)
Get full text
Journal Article
Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac
Melarange, R, Gentry, C, Blower, P R, Toseland, C D, Spangler, R
Published in European journal of rheumatology and inflammation (1994)
Get more information
Published in European journal of rheumatology and inflammation (1994)
Journal Article
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77‐LH‐28‐1
Langmead, C J, Austin, N E, Branch, C L, Brown, J T, Buchanan, K A, Davies, C H, Forbes, I T, Fry, V A H, Hagan, J J, Herdon, H J, Jones, G A, Jeggo, R, Kew, J N C, Mazzali, A, Melarange, R, Patel, N, Pardoe, J, Randall, A D, Roberts, C, Roopun, A, Starr, K R, Teriakidis, A, Wood, M D, Whittington, M, Wu, Z, Watson, J
Published in British journal of pharmacology (01.07.2008)
Published in British journal of pharmacology (01.07.2008)
Get full text
Journal Article
Beta 1-selective adrenoceptor antagonists. 3. 4-Azolyl-linked phenoxypropanolamines
Machin, P J, Hurst, D N, Bradshaw, R M, Blaber, L C, Burden, D T, Melarange, R A
Published in Journal of medicinal chemistry (01.04.1984)
Published in Journal of medicinal chemistry (01.04.1984)
Get full text
Journal Article
beta 1-selective adrenoceptor antagonists. 2. 4-ether-linked phenoxypropanolamines
Machin, P J, Hurst, D N, Bradshaw, R M, Blaber, L C, Burden, D T, Fryer, A D, Melarange, R A, Shivdasani, C
Published in Journal of medicinal chemistry (01.11.1983)
Published in Journal of medicinal chemistry (01.11.1983)
Get full text
Journal Article